1. Home
  2. TII vs ANIK Comparison

TII vs ANIK Comparison

Compare TII & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Titan Mining Corporation

TII

Titan Mining Corporation

N/A

Current Price

$3.25

Market Cap

198.5M

Sector

N/A

ML Signal

N/A

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

N/A

Current Price

$20.91

Market Cap

200.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TII
ANIK
Founded
2012
1983
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.5M
200.9M
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
TII
ANIK
Price
$3.25
$20.91
Analyst Decision
Strong Buy
Buy
Analyst Count
2
1
Target Price
$6.38
$17.00
AVG Volume (30 Days)
447.5K
108.5K
Earning Date
05-11-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.16
EPS
N/A
N/A
Revenue
N/A
$112,819,000.00
Revenue This Year
$4.20
$5.98
Revenue Next Year
$3.46
$7.42
P/E Ratio
$25.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.81
$8.56
52 Week High
$5.65
$22.88

Technical Indicators

Market Signals
Indicator
TII
ANIK
Relative Strength Index (RSI) 63.55 55.58
Support Level $2.55 $14.00
Resistance Level $3.28 $22.70
Average True Range (ATR) 0.21 0.92
MACD 0.02 -0.25
Stochastic Oscillator 78.76 34.66

Price Performance

Historical Comparison
TII
ANIK

About TII Titan Mining Corporation

Titan Mining Corp is a Canadian natural resources company. The company is engaged in the acquisition, exploration, development, and extraction of mineral properties. The company owns an interest in the Empire State Mine in Northern New York State, United States, and Kilbourne Graphite Project. The Company operates one reportable segment, mineral production and exploration in the United States.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: